What we found on the web about Mepha Ag
Bluepharma's production plant was acquired from Bayer AG when, at the end of the 1990s ... pharmaceuticals brands and companies such as Teva, Ivax, Arrow, EG LABO , Bexal , Mepha ...
announced today that ithas signed an agreement to acquire Mepha AG and its subsidiaries, aprofitable, privately-held, Swiss-based pharmaceutical company. ...
... Business Intelligence focused on Research and Development in the Biopharmaceutical Industry, Cephalon, Inc. Announces Agreement to Acquire Mepha AG ...
"Good medicines at healthy prices" is the motto used by Switzerland's leading provider of generic drugs Mepha AG. The increasing cost of health insurance means that more and more ...
Pharmaceutical strategic business consultancy involved in partnering, licensing, ... About Mepha AG. Founded in 1949, Mepha is a Swiss-based pharmaceutical company marketing ...
Cephalon, Inc. Announces Agreement to Acquire Mepha AG- Expands Range of Products and Reach in Europe, Africa, and the Middle East- Transaction Expected to be ...
BOSTON (Reuters) - U.S. drugmaker Cephalon Inc said on Monday it will buy Mepha AG, the Swiss generic drugmaker owned by Germany's Merckle family, for about $590 million ...
Cephalon, Inc. Announces Agreement to Acquire Mepha AG CEPHALON ... FRAZER, Philadelphia, AESCH, Switzerland and MAISONS ALFORT, France, February 1 (ots/PRNewswire) -- Cephalon ...
About Mepha AG. Founded in 1949, Mepha is a Swiss-based pharmaceutical ... Furthermore, Mepha is active in malaria research offering innovative life-saving ...
Announces Agreement to Acquire Mepha AG --Expands Range of Products ... Mepha has specific expertise in innovative dosage formulations and markets both ...
Special Reports. After-Hours Movers 2/1: BKS, RTEC, ARRY, CCK Higher; STSA, CDR, ICUI, ADVS Lower; Trading Radar for 02/02: Dow Chemical (DOW), Hershey (HSY), Marathon Oil (MRO ...
UBS AG shares fell after the Swiss justice minister underscored the risk to the Swiss ... Cephalon said Monday it will buy Swiss-based drug company Mepha AG for an estimated $590 ...
Cephalon Inc. agreed to acquire Swiss drug maker Mepha AG for about $590 million in an all-cash deal that doubles the biopharmaceutical company's international business and ...
Mepha AG, Aesch - Vertrieb und Herstellung von Arzneimitteln und chemischen Produkten. Die Gesellschaft kann sich an anderen Unternehmungen beteiligen, ...
Mepha Pharma AG. Dornacherstrasse 114 Postfach 445 CH-4147 Aesch / Basel SWITZERLAND Phone +41 (61) 705 43 43 Fax +41 (61) 705 43 38 E-mail contact@mepha.ch
Cephalon, Inc. Announces Agreement to Acquire Mepha AG ... Mepha has specific expertise in innovative dosage formulations and markets both generic and branded generic products. ...
FRAZER, Pa. (AP) -- Biotechnology company Cephalon said Monday it will buy Swiss-based drug company Mepha AG for an estimated $590 million.The Frazer, Pa., company said
The deal is not the first in Cephalon's recent history. ... Cephalon (CEPH) agreed to acquire Swiss drug maker Mepha AG for $590 million, the companies announced on Monday. ...
Announces Agreement to Acquire Mepha AG. Expands Range of Products and Reach in Europe, ... Mepha has specific expertise in innovative dosage formulations and markets both ...
Entry added by Creative Administrator
Creative Administrator also edited:
Here is what users have to say about Mepha Ag

Welcome to Investorator

Investorator is your guide to the sprawling world wide web. The directory aims to provide a useful guide made by users. You can share your knowledge as well - simply sign up and edit your first entry. For questions just contact the team at support - at - investorator.com.

Are you an investor in Mepha Ag? What do you think how Mepha Ag will develop?

Should someone else buy or sell Mepha Ag? Why?

Comments

You must be logged in to post a comment.

No comments yet on this topic. Be the first one!
Blogs for Mepha Ag
Blog-n-play.com Branded software technology blogs, podcast ... Under the terms of the agreement, Cephalon will purchase Mepha AG for CHF 622.5 million, or an estimated $590 ...
International biopharmaceutical company Cephalon Inc. today announced it has signed an agreement to acquire Mepha AG, a profitable, privately held, Swiss-based ...
Announces Agreement to Acquire Mepha AG. Expands Range of Products and ... Syndicated stories and blog feeds, all rights reserved by the author. ...
Biotechnology company Cephalon said Monday it will buy Swiss-based drug company Mepha AG for an estimated $590 million.
Announces Agreement to Acquire Mepha AG. FRAZER, Philadelphia, AESCH, Switzerland and ... generics business after acquiring Mepha AG, a privately held Swiss ...